Expressive writing to help manage stress in cancer survivors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of expressive writing as a method to manage stress among cancer survivors. Participants are randomized into two groups: one engages in expressive writing about their experiences, while the other writes about neutral topics. Both groups complete questionnaires regarding their mood, health, and income at various intervals. The study aims to assess the feasibility of this virtual intervention and its preliminary impact on stress levels in cancer survivors, particularly during challenging times like the COVID-19 pandemic.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* At least 18 years old
* Have a diagnosis of cancer within the past 3 years
* Are able to speak and read in English
* Have access to a computer or smart phone with internet connection
* All disease sites and all cancer stages are eligible for enrollment

Exclusion Criteria:

* Inability to provide informed consent
* Non-English speakers will be excluded because this is a feasibility study that will enroll only a limited number of participants

Where it's running

• M D Anderson Cancer Center
  Houston, Texas, United States Recruiting

Study contacts

• Principal investigator: Qian Lu — M.D. Anderson Cancer Center
• Study coordinator: Qian LU, MD,PHD
• Email: qlu@mdanderson.org
• Phone: 713-745-8324

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Video education to boost knowledge and interest in cancer clinical trials

  Adults in the Detroit area will watch a short educational video to see if it increases their knowledge about and interest in cancer clinical trials.

  Recruiting Barbara Ann Karmanos Cancer Institute · Detroit, Michigan · NCT06501040

• Using alteplase to improve fluid drainage and breathlessness in patients with malignant pleural effusion

  This study tests if the medication alteplase can help people with fluid buildup in the lungs feel better and breathe easier when regular drainage isn’t enough.

  Recruiting Early Phase 1 M.D. Anderson Cancer Center · Baltimore, Maryland and 1 other locations · NCT06184321

• Using weighted blankets to reduce anxiety in cancer patients during infusions

  This study is testing whether using weighted blankets can help reduce anxiety in cancer patients during their first infusion therapy.

  Recruiting Ohio State University Comprehensive Cancer Center · Columbus, Ohio · NCT06089408

• Letermovir to prevent cytomegalovirus after pediatric stem cell transplant

  This study will try giving letermovir to CMV-positive children and adolescents receiving allogeneic stem cell transplants to see if it lowers CMV infections after transplant compared with the expected rate without prophylaxis.

  Recruiting at 32 sites Phase 3 Children's Oncology Group · Birmingham, Alabama and 32 other locations · NCT05711667

• Collecting blood and tissue samples for HIV/AIDS-related cancer research

  This study is collecting blood and tissue samples from people living with HIV and related cancers to help researchers learn more about how HIV affects cancer development.

  Recruiting at 8 sites AIDS Malignancy Consortium · La Jolla, California and 7 other locations · NCT05663502

• Collecting blood samples to evaluate tests for early cancer detection

  This study is collecting blood and tissue samples from people with and without cancer to see if new tests can help detect cancer earlier.

  Recruiting at 619 sites Alliance for Clinical Trials in Oncology · Anchorage, Alaska and 750 other locations · NCT05334069

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.